BioCentury
ARTICLE | Clinical News

Rigel preclinical data

December 12, 2005 8:00 AM UTC

In a xenograft mouse model of AML, R406 inhibited tumor growth in a dose-dependent manner. R406 is a syk and FLT3 kinase inhibitor. Data will be presented at the American Society of Hematology meetin...